LMAT bullish pushLMAT about to break the long strong resistance of 92
It is a buy and accumulate once it closes a day above 92 level
Stop loss can be 90
This is a strong fundamental stock and is in a bull trend so the trend should be followed
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.84 USD
30.11 M USD
193.48 M USD
20.47 M
About LeMaitre Vascular, Inc.
Sector
Industry
CEO
George W. LeMaitre
Website
Headquarters
Burlington
Founded
1983
FIGI
BBG000LY1HS2
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.
LeMaitre Vascular (LMAT:NASDAQ) Favourable Long-TermConsolidations Present Investment Entry Opportunity
LeMaitre Vascular's stock demonstrates promising prospects for investors seeking long-term gains, especially considering recent consolidations in the market that have created an appealing entry point.
Strong Q2 Performance and Anticipated Continu
H&S BOTTOMInteresting accumulation area that is developing over 200SMA support area,
Head and Shoulders weekly target suggest a R/R of 2 for longs.
ACCUMULATIONInteresting accumulation area developing with rising RSI, suggesting upward pressure could build up.
Look for a breakout confirmed by weekly close and increase in volume.
$LMAT can rise in the next daysContextual immersion trading strategy idea.
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide.
The demand for shares of the company looks higher than the supply.
This and other conditions
Beats estimatesSales grew 9% to $28.4 million. That was well ahead of the $25.9 million that analysts had projected.
Operating income surged 14% to $7.2 million.
Net income grew 41% to $6 million, or $0.30 per share. That figure blew past the $0.20 that Wall Street was expecting.
The board of directors approved a
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LMAT is 104.25 USD — it has increased by 3.15% in the past 24 hours. Watch LeMaitre Vascular, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange LeMaitre Vascular, Inc. stocks are traded under the ticker LMAT.
LMAT stock has risen by 16.81% compared to the previous week, the month change is a 15.59% rise, over the last year LeMaitre Vascular, Inc. has showed a 111.25% increase.
We've gathered analysts' opinions on LeMaitre Vascular, Inc. future price: according to them, LMAT price has a max estimate of 117.00 USD and a min estimate of 85.00 USD. Watch LMAT chart and read a more detailed LeMaitre Vascular, Inc. stock forecast: see what analysts think of LeMaitre Vascular, Inc. and suggest that you do with its stocks.
LMAT reached its all-time high on Nov 1, 2024 with the price of 101.67 USD, and its all-time low was 1.54 USD and was reached on Feb 19, 2009. View more price dynamics on LMAT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LMAT stock is 5.02% volatile and has beta coefficient of 0.90. Track LeMaitre Vascular, Inc. stock price on the chart and check out the list of the most volatile stocks — is LeMaitre Vascular, Inc. there?
Today LeMaitre Vascular, Inc. has the market capitalization of 2.34 B, it has increased by 2.85% over the last week.
Yes, you can track LeMaitre Vascular, Inc. financials in yearly and quarterly reports right on TradingView.
LeMaitre Vascular, Inc. is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
LMAT earnings for the last quarter are 0.49 USD per share, whereas the estimation was 0.43 USD resulting in a 12.64% surprise. The estimated earnings for the next quarter are 0.49 USD per share. See more details about LeMaitre Vascular, Inc. earnings.
LeMaitre Vascular, Inc. revenue for the last quarter amounts to 54.82 M USD, despite the estimated figure of 53.50 M USD. In the next quarter, revenue is expected to reach 55.98 M USD.
LMAT net income for the last quarter is 11.14 M USD, while the quarter before that showed 11.83 M USD of net income which accounts for −5.79% change. Track more LeMaitre Vascular, Inc. financial stats to get the full picture.
Yes, LMAT dividends are paid quarterly. The last dividend per share was 0.16 USD. As of today, Dividend Yield (TTM)% is 0.59%. Tracking LeMaitre Vascular, Inc. dividends might help you take more informed decisions.
LeMaitre Vascular, Inc. dividend yield was 0.99% in 2023, and payout ratio reached 41.71%. The year before the numbers were 1.09% and 53.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 9, 2024, the company has 630.00 employees. See our rating of the largest employees — is LeMaitre Vascular, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LeMaitre Vascular, Inc. EBITDA is 59.21 M USD, and current EBITDA margin is 24.08%. See more stats in LeMaitre Vascular, Inc. financial statements.
Like other stocks, LMAT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LeMaitre Vascular, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LeMaitre Vascular, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LeMaitre Vascular, Inc. stock shows the strong buy signal. See more of LeMaitre Vascular, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.